Search
for

    Glossary Secukinumab

    biologic medication treating autoimmune conditions by inhibiting interleukin-17A

    Secukinumab is a biologic medication used to treat autoimmune conditions such as psoriasis, ankylosing spondylitis, and psoriatic arthritis. It works by inhibiting interleukin-17A, a protein that plays a key role in the inflammatory process, thereby reducing inflammation and helping to control symptoms.

    Sort by

    Research 30 of 230

    1. Repigmentation and new growth of hairs after anti–interleukin-17 therapy with secukinumab for psoriasis JAAD Case Reports · 2018 · 12 citations
    2. Successful treatment of refractory folliculitis decalvans with secukinumab Australasian Journal of Dermatology · 2019 · 10 citations
    3. Alopecia Areata After Initiation of Secukinumab Therapy for Plaque Psoriasis Cureus · 2023 · 8 citations
    4. Generalized hypertrichosis due to secukinumab in a patient with moderate psoriasis: A case of serendipity or zemblanity? Dermatologic therapy · 2019 · 5 citations
    5. Excessive hair growth in a patient with psoriatic erythroderma following secukinumab administration European Journal of Dermatology · 2018 · 3 citations
    6. Combination of secukinumab and acitretin for generalized pustular psoriasis: A case report and review of literature Journal of International Medical Research · 2024 · 2 citations
    7. Secukinumab-Induced Alopecia Areata Successfully Treated with Tofacitinib in a Patient with Palmoplantar Pustulosis Clinical, cosmetic and investigational dermatology · 2023 · 1 citations
    8. Simultaneous HBV Reactivation and Hair Discoloration Under Secukinumab Treatment. PubMed · 2025
    9. 496 Understanding the mechanism of action of secukinumab using lesional hidradenitis suppurativa skin organ culture Journal of Investigative Dermatology · 2024
    10. Ophiasis Alopecia Areata in a Patient With Spondyloarthritis on Secukinumab: A Case Report and Review of the Literature Curēus · 2024
    11. Eccema dishidrótico palmoplantar asociado a secukinumab Dermatología argentina · 2020
    12. New onset alopecia areata during secukinumab therapy Dermatologic Therapy · 2019 · 14 citations
    13. Alopecia Areata: an Update on Etiopathogenesis, Diagnosis, and Management Clinical Reviews in Allergy & Immunology · 2021 · 290 citations
    14. S2k guideline for the treatment of hidradenitis suppurativa / acne inversa – Short version JDDG Journal der Deutschen Dermatologischen Gesellschaft · 2024 · 41 citations
    15. New developments in the molecular treatment of ichthyosis: review of the literature Orphanet journal of rare diseases · 2022 · 21 citations
    16. Comparative efficacy of oral Janus kinase inhibitors and biologics in adult alopecia areata: A systematic review and Bayesian network meta‐analysis Journal of the European Academy of Dermatology and Venereology · 2024 · 20 citations
    17. Learning From Success and Failure: Biologics for Non-approved Skin Diseases Frontiers in immunology · 2019 · 20 citations
    18. Systematic review of newer agents for the management of alopecia areata in adults: Janus kinase inhibitors, biologics and phosphodiesterase‐4 inhibitors 2022 · 12 citations
    19. Paradoxical Skin Reaction to Certolizumab, an Overlap of Pyoderma Gangrenosum and Psoriasis in a Young Woman Treated for Ankylosing Spondylitis: Case Report with Literature Review Dermatology and therapy · 2020 · 12 citations
    20. Successful treatment of palmoplantar pustular psoriasis with brodalumab European Journal of Dermatology · 2018 · 9 citations
    21. Granulomatous pigmented purpuric dermatosis containing Propionibacterium acnes European Journal of Dermatology · 2018 · 8 citations
    22. Optimal Management of Plaque Psoriasis in Adolescents: Current Perspectives Psoriasis : Targets and Therapy · 2020 · 4 citations
    23. Generalized hypertrichosis associated with the use of interleukin 17 blockers in 2 patients with psoriasis JAAD Case Reports · 2020 · 3 citations
    24. Cytokine-Targeting Biologic Therapies for Alopecia Areata: A Comprehensive Review of Mechanism of Action, Clinical Efficacy, and Adverse Events Biologics · 2025 · 2 citations
    25. Hidradenitis suppurativa secondary to treatment with a gamma secretase inhibitor 2023 · 1 citations
    26. Cytokine-targeted treatment in alopecia areata - new possibilities? Prospects in Pharmaceutical Sciences · 2023 · 1 citations
    27. Paradoxical Alopecia Areata Induced by IL‐17 and IL‐23 Inhibitors: A Systematic Review JEADV Clinical Practice · 2026
    28. SYSTEMATIC REVIEW OF PHARMACOTHERAPY STRATEGIES IN THE MANAGEMENT OF HIDRADENITIS SUPPURATIVA International Journal of Innovative Technologies in Social Science · 2025
    29. Advances in the Molecular Pathogenesis and Targeted Therapy of Psoriasis Galen Medical Journal · 2025
    30. Netherton Syndrome: A Case-Based Review of Diagnosis, Management, and Emerging Treatments. PubMed · 2025